IL18 and Sepsis: In models of sepsis, for example, injection of a low or moderate dose of lipopolysaccharide (LPS) induces a moderate rise in IL-18 levels that enhances anti-bacterial host defenses, while injection with high doses results in sustained, high levels of IL-18, that impair host antibacterial defenses [25].